The FTC Is Digging Into Reasoning Behind Drug Shortages In The U.S.

Americans have faced acute shortages of critical drugs for years, the inquiry aims to reveal factors driving these shortages and how to solve the issue.

The U.S. Federal Trade Commission is investigating a shortage of generic drugs like chemotherapies and antibiotics.

The agency is looking into the role played by drug distributors and other companies that purchase medicines for U.S. hospitals in regards to the shortages.

The FTC will seek information about drug distributors and hospital purchasing groups and their contracting practices, market concentration as well as compensation.

It will examine if these companies have misused their market power to push down prices of generic drugs so much that some manufacturers cannot profit, forcing a halt in production which results in shortages.

Americans have faced acute shortages of critical drugs for years, the inquiry aims to reveal factors driving these shortages and how to solve the issue.